2022 年副百日咳博德特氏菌在法国的短暂再现。

Valérie Bouchez, Julie Toubiana, Sophie Guillot, Parapertussis Study Group, Fatima Aït El Belghiti, Annie Landier, Nathalie Armatys, Sabine Trombert-Paolantoni, Anaïs Soares, Carla Rodrigues, Sylvain Brisse
{"title":"2022 年副百日咳博德特氏菌在法国的短暂再现。","authors":"Valérie Bouchez, Julie Toubiana, Sophie Guillot, Parapertussis Study Group, Fatima Aït El Belghiti, Annie Landier, Nathalie Armatys, Sabine Trombert-Paolantoni, Anaïs Soares, Carla Rodrigues, Sylvain Brisse","doi":"10.1099/jmm.0.001843","DOIUrl":null,"url":null,"abstract":"<p><p>Between March and October 2022, a peak of detection of <i>Bordetella parapertussis</i> by qPCR, real-time PCR was observed in France.<b>Hypothesis/Gap Statement.</b> Whether this peak was due to resurgence from previous circulating lineages or reintroduction into the country was unknown.<b>Objective.</b> The objective of this study is to understand <i>B. parapertussis-</i>transient increase observed in France in 2022 whereas it had virtually stopped being reported since the start of the COVID-19 pandemic in 2020.<b>Methods.</b> We analysed real-time PCR (qPCR) data from the two largest French outpatient laboratories performing whooping cough diagnosis and characterized all <i>B. parapertussis</i> isolates collected in the 2016-2022 period by the French National Reference Centre for Whooping Cough.<b>Results.</b> Microbiological analyses reveal that 13 of 18 bacterial isolates collected in 2022 produce the vaccine antigen pertactin, whereas none of the 22 isolates collected in the 2016-2021 period did.<b>Conclusion.</b> We hypothesize a re-introduction of <i>B. parapertussis</i> from regions of the world where whole-cell vaccines are still in use.</p>","PeriodicalId":94093,"journal":{"name":"Journal of medical microbiology","volume":"73 7","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Transient reemergence of <i>Bordetella parapertussis</i> in France in 2022.\",\"authors\":\"Valérie Bouchez, Julie Toubiana, Sophie Guillot, Parapertussis Study Group, Fatima Aït El Belghiti, Annie Landier, Nathalie Armatys, Sabine Trombert-Paolantoni, Anaïs Soares, Carla Rodrigues, Sylvain Brisse\",\"doi\":\"10.1099/jmm.0.001843\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Between March and October 2022, a peak of detection of <i>Bordetella parapertussis</i> by qPCR, real-time PCR was observed in France.<b>Hypothesis/Gap Statement.</b> Whether this peak was due to resurgence from previous circulating lineages or reintroduction into the country was unknown.<b>Objective.</b> The objective of this study is to understand <i>B. parapertussis-</i>transient increase observed in France in 2022 whereas it had virtually stopped being reported since the start of the COVID-19 pandemic in 2020.<b>Methods.</b> We analysed real-time PCR (qPCR) data from the two largest French outpatient laboratories performing whooping cough diagnosis and characterized all <i>B. parapertussis</i> isolates collected in the 2016-2022 period by the French National Reference Centre for Whooping Cough.<b>Results.</b> Microbiological analyses reveal that 13 of 18 bacterial isolates collected in 2022 produce the vaccine antigen pertactin, whereas none of the 22 isolates collected in the 2016-2021 period did.<b>Conclusion.</b> We hypothesize a re-introduction of <i>B. parapertussis</i> from regions of the world where whole-cell vaccines are still in use.</p>\",\"PeriodicalId\":94093,\"journal\":{\"name\":\"Journal of medical microbiology\",\"volume\":\"73 7\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of medical microbiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1099/jmm.0.001843\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of medical microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1099/jmm.0.001843","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

2022 年 3 月至 10 月间,法国出现了通过 qPCR 和实时 PCR 检测副百日咳博德特菌的高峰。这一高峰是由于以前流行的菌株再次出现还是再次传入法国尚不清楚。本研究的目的是了解 2022 年在法国观察到的副百日咳杆菌瞬时增加,而自 2020 年 COVID-19 大流行开始以来,几乎不再有副百日咳杆菌的报告。我们分析了法国两个最大的百日咳诊断门诊实验室的实时 PCR(qPCR)数据,并对法国国家百日咳参考资料中心在 2016-2022 年期间收集的所有副百日咳杆菌分离物进行了特征描述。微生物学分析表明,2022 年收集的 18 个细菌分离株中有 13 个能产生疫苗抗原 pertactin,而 2016-2021 年收集的 22 个分离株中没有一个能产生 pertactin。我们假设副百日咳杆菌从世界上仍在使用全细胞疫苗的地区重新引入。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Transient reemergence of Bordetella parapertussis in France in 2022.

Between March and October 2022, a peak of detection of Bordetella parapertussis by qPCR, real-time PCR was observed in France.Hypothesis/Gap Statement. Whether this peak was due to resurgence from previous circulating lineages or reintroduction into the country was unknown.Objective. The objective of this study is to understand B. parapertussis-transient increase observed in France in 2022 whereas it had virtually stopped being reported since the start of the COVID-19 pandemic in 2020.Methods. We analysed real-time PCR (qPCR) data from the two largest French outpatient laboratories performing whooping cough diagnosis and characterized all B. parapertussis isolates collected in the 2016-2022 period by the French National Reference Centre for Whooping Cough.Results. Microbiological analyses reveal that 13 of 18 bacterial isolates collected in 2022 produce the vaccine antigen pertactin, whereas none of the 22 isolates collected in the 2016-2021 period did.Conclusion. We hypothesize a re-introduction of B. parapertussis from regions of the world where whole-cell vaccines are still in use.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Antifungal resistance, clinical outcome and clinico-microbiological correlation in ocular infections due to common melanized fungi Curvularia lunata and Lasiodiplodia theobromae in South India. Genotypic analysis of Shiga toxin-producing Escherichia coli clonal complex 17 in England and Wales, 2014-2022. Nanomotion technology: an innovative method to study cell metabolism in Escherichia coli, as a potential indicator for tolerance. Association of gut microbiota with allograft injury in kidney transplant recipients: a comparative profiling through 16S metagenomics and quantitative PCR. Chronic Strongyloides stercoralis infection in Fijian migrants to the UK.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1